%0 Journal Article
%A 
%T The clinical importance of fibroblast growth factor 23 on advanced non-small cell lung cancer patients without druggable alterations in genes as EGFR or ALK or ROS1 Fibroblast growth factor 23
%D 2020
%F 
%P 365-369
%V 4
%N 3
%R doi:10.14744/ejmi.2020.60165
%U https://dx.doi.org/10.14744/ejmi.2020.60165